SAN DIEGO—(BUSINESS WIRE)—Nov. 1, 2006—ACADIA PharmaceuticalsInc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovativetechnology to fuel drug discovery and clinical development of noveltreatments for central nervous system disorders, today announced thatit will present at the following investor conferences:
- The Rodman & Renshaw 8th Annual Healthcare Conference onWednesday, November 8, 2006 at 11:20 a.m. Eastern Time at TheNew York Palace Hotel in New York City.
- The San Diego BIOCOM Investor Conference on Wednesday,November 15, 2006 at 9:20 a.m. Pacific Time at the San DiegoMarriott Del Mar in San Diego.
- The JMP Securities Sector Focus Conference on Thursday,November 16, 2006 at 10:00 a.m. Eastern Time at the FourSeasons Hotel in Boston.
- The Piper Jaffray Healthcare Conference on Wednesday, November29, 2006 at 10:00 a.m. Eastern Time at the Pierre Hotel in NewYork City.
Live webcasts of these presentations will be accessible on thecompany's website, www.acadia-pharm.com, under the investors sectionand an archived recording will be available on the website for twoweeks following the presentation.
About ACADIA Pharmaceuticals
ACADIA is a biopharmaceutical company utilizing innovativetechnology to fuel drug discovery and clinical development of noveltreatments for central nervous system disorders. ACADIA currently hasfive Phase II-stage clinical programs as well as a portfolio ofpreclinical and discovery assets directed at large unmet medicalneeds, including schizophrenia, Parkinson's disease, sleep maintenanceinsomnia, and neuropathic pain. All of the drug candidates in ACADIA'sproduct pipeline emanate from discoveries made using its proprietarydrug discovery platform. ACADIA's corporate headquarters is located inSan Diego, California and it maintains research and developmentoperations in both San Diego and Malmo, Sweden.
CONTACT: ACADIA Pharmaceuticals Inc.
Lisa Barthelemy, Director, Investor Relations
Thomas H. Aasen, Vice President and
Chief Financial Officer
858-558-2871